Top 50 Health Care Angel Investors in Israel (May 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Marius Nacht
Angel
|
5 | Israel, United States, Switzerland | Series A, Seed, Series B | Artificial Intelligence, Machine Learning, Health Care | $5.3M–$120M |
|
Howard Morgan
Angel
|
3 | United States, Israel, India | Seed, Series A, Series B | Software, Artificial Intelligence, Health Care | $857k–$25M |
|
Ran Tuttnauer
Angel
|
3 | Israel, Canada, United States | Seed, Series A | Health Care, Big Data, Medical Device | |
|
Prof. Rafael Beyar
Angel
|
2 | Israel | Seed, Series A | Medical, Medical Device, Machine Learning | |
|
Shmuel Cabilly
Angel
|
2 | Israel, United States | Series B, Series C | Health Care, Medical, Artificial Intelligence | |
|
Moshe Gaon
Angel
|
2 | Israel, United States | Seed, Series A, Convertible Note | Advertising, Association, Social Media Marketing | |
|
Zohar Gilon
Angel
|
2 | Israel, United States | Seed, Series A, Series B | Software, Internet, Medical Device | $1.5M–$15M |
|
Dov Moran
Angel
|
2 | Israel, United States | Series A, Seed, Series B | Semiconductor, Hardware, Health Care | $1.2M–$74M |
|
Yehuda Zisapel
Angel
|
2 | Israel | Series A, Seed | Medical Device, Medical, Health Care | |
|
Assaf Wand
Angel
|
2 | United States, Brazil, France | Seed, Series A, Series B | Insurance, Health Care, Information Technology | $3M–$6.6M |
|
Yaron Samid
Angel
|
2 | United States, Israel, Brazil | Seed, Pre-Seed, Series A | Software, Apps, Cyber Security | $4M–$13M |
|
Ron C
Angel
|
2 | Israel | Seed | Health Care, Therapeutics, Medical Device | |
|
Shimon Eckhouse
Angel
|
2 | Israel | Seed | Medical, Biotechnology, Fitness | |
|
Mazal CB
Angel
|
2 | Israel | Seed | Health Care, Therapeutics, Medical Device | |
|
Lewis Pell
Angel
|
1 | Israel | Health Care, Therapeutics, Medical Device | ||
|
Avishai Abrahami
Angel
|
1 | Israel, United States, Italy | Seed, Series A, Pre-Seed | Software, Internet, Social Media | $250k–$9.5M |
|
Ronald Cohen
Angel
|
1 | Israel, United States, Poland | Series A, Seed | Health Care, Software, Artificial Intelligence | $1.7M–$30M |
|
Lyndon Babtiste
Angel
|
1 | Israel | Seed | mHealth, Blockchain, Health Care | |
|
Beni Nofech
Angel
|
1 | Israel | Pre-Seed, Series A | Food and Beverage, Food Processing, Nutrition | |
|
Lily Sarafan
Angel
|
1 | United States, Israel | Seed, Series A | Health Care, Wellness, Enterprise Software | |
|
David Agus
Angel
|
1 | Israel | Series A | Health Care, Health Diagnostics, Artificial Intelligence | |
|
Rick Klausner
Angel
|
1 | United States, Israel, United Kingdom | Series A, Series B, Series E | Biotechnology, Therapeutics, Life Science | $30M–$42M |
|
Moshe Shoham
Angel
|
1 | Israel | Pre-Seed | Medical, Health Care, Artificial Intelligence | |
|
Alan Patricof
Angel
|
1 | United States, Kenya, Spain | Series A, Seed | Health Care, Financial Services, Finance | $1.5M–$15M |
|
Sake Bosch
Angel
|
1 | The Netherlands, France, Israel | Series A, Seed, Series B | Software, E-Commerce, Food and Beverage | $1.8M–$78M |
|
Nancy Spielberg
Angel
|
1 | Israel | Seed | Wearables, Health Care, Machine Learning | |
|
Zohar Zisapel
Angel
|
1 | Israel, United States | Series A, Seed, Series B | Cyber Security, Information Technology, Security | $2.6M–$18M |
|
Daniel Koss
Angel
|
1 | Israel | Seed | Medical Device, Clinical Trials, Health Diagnostics | |
|
Haim Chizic
Angel
|
1 | Israel | Seed | Medical Device, Clinical Trials, Health Diagnostics | |
|
Tzachi Arabov
Angel
|
1 | Israel | Seed | Medical Device, Clinical Trials, Health Diagnostics | |
|
Joshua Riff
Angel
|
1 | Israel | Seed | Software, Wellness, Analytics | |
|
Anne Wojcicki
Angel
|
1 | United States, United Kingdom, Canada | Seed, Series A, Series B | Health Care, Medical, Biotechnology | $765k–$20M |
|
Ole T. Jensen
Angel
|
1 | Israel | Biotechnology, Medical Device | ||
|
Romain Afflelou
Angel
|
1 | France, United States, Israel | Seed, Series A, Pre-Seed | Health Care, FinTech, Software | $1M–$43M |
|
Chris Mansi
Angel
|
1 | United States, Israel | Series A | Health Care, Medical, Software | $13M–$25M |
|
Brock Weatherup
Angel
|
1 | Israel, United States | Seed | EdTech, Medical, mHealth | $550k–$880k |
|
Ariel Yaar
Angel
|
1 | Israel, United States, United Kingdom | Seed, Series A, Series B | Software, Health Care, CRM | |
|
Robert Nelsen
Angel
|
1 | United States, China, Israel | Series A, Series B, Series C | Biotechnology, Health Care, Pharmaceutical | $15M–$167M |
|
Gigi Levy Weiss
Angel
|
1 | Israel, United States, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, SaaS | $400k–$45M |
|
Noam Solomon
Angel
|
1 | Israel | Seed | Software, Wellness, Health Care | |
|
Shahar Tzafrir
Angel
|
1 | Israel, United States | Series A, Seed, Series B | Software, Artificial Intelligence, Information Technology | $3M–$40M |
|
Larry Ellison
Angel
|
1 | United States, Spain, Israel | Series C, Series G | Software, Health Care, Biotechnology | $11M–$50M |
|
Rafi Gidron
Angel
|
1 | Israel, United States, United Kingdom | Seed, Angel, Series B | Artificial Intelligence, Cyber Security, Analytics | $3M–$8M |
|
Danny Hadar
Angel
|
1 | Israel, United States | Seed, Series B | Software, Artificial Intelligence, Machine Learning | |
|
Sacha Levy
Angel
|
1 | United States, Israel | Seed, Debt Financing | Software, Health Care, mHealth | $1.6M–$3M |
|
Bradley M. Bloom
Angel
|
1 | Israel, United States | Seed, Series A, Series B | Food and Beverage, Sports, Fitness | |
|
David E. Weekly
Angel
|
1 | United States, Israel | Seed, Angel, Pre-Seed | Robotics, Drones, Aerospace | |
|
Eyal Gura
Angel
|
1 | United States, Israel, Belgium | Series A, Seed, Series B | Software, Mobile, Artificial Intelligence | $1M–$19M |
|
Vivek Garipalli
Angel
|
1 | United States, India, Brazil | Seed, Series A, Series B | Health Care, Medical, Machine Learning | $1.4M–$100M |
|
Amir Gross
Angel
|
1 | Israel | Medical, Health Care, Medical Device | ||
| Access all 82 angel investors in Israel Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Marius Nacht, one of Check Point’s founders, has served as Chairman of our board of directors since 2015. Nacht has also served as one of our directors since we were incorporated in 1993. From 1999 through 2005, Nacht held Senior Vice President roles at Check Point. Nacht earned a B.S. (cum laude) in Physics and Mathematics from the HebrewUniversity of Jerusalem in 1983, and an M.S. in Electrical Engineering and Communication Systems from Tel Aviv University in 1987.
Show more...Investment focus
- Industry: Artificial Intelligence, Machine Learning, Health Care
- Stage:Series A, Seed, Series B
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 32
- Round size: Seed $10M–$120M; Series A $5.3M–$17M; Series B $8M–$74M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Wisdo Health — Our award-winning social health platform utilizes SDOH assessments and pro-social measures to increase quality of life and decrease medical spending.
- WaveBL — WAVE BL lets you digitally issue, transfer, sign, endorse and surrender trade documents while cutting costs and eliminating fraud.
- CommonGround-AI — We provide a software solution that delivers the benefits of face to face plus a whole lot more.
Howard Morgan is currently the Chairman of B Capital. He co-founded First Round Capital with Josh Kopelman as the first professional Seed Stage Fund, where he remains Senior Advisor. Prior to First Round, Howard helped found Idealab with Bill Gross, and served as President of Renaissance Technologies, which he co-founded with Jim Simons. Prior tohis move into the business of technology, Howard served as a professor at the Wharton School and the Moore School, both at the University of Pennsylvania, as well as at Cornell University. He is also an Executive Fellow at UC Berkeley. Howard’s research on user interface technology and the optimization of computer networks was critical to bringing the ARPAnet to Philadelphia in the 1970s. Through this early internet participation, he helped corporate and government agencies use technology to improve the efficiency of both large and small organizations. He also has deep experience with very large databases, and served as the first Editor of the ACM Transactions on Database Systems Journal. Throughout his career, Howard has sought out great people and nurtured them so that they could realize their dreams. His mentees have included both PhD students researching a key topic, and early stage entrepreneurs building companies and taking them from seed stage through initial public offerings. He currently serves as a Director of Idealab, and he is on the board of several non-profits including Cold Spring Harbor Laboratories and Math For America. He has also served on a number of public company Boards, including Franklin Electronic Publishers and Internet Brands, Inc. He was CEO of Kentek and Franklin during various turnover or transitional periods and in 1997 he was named Delaware Valley Entrepreneur of the Year. Howard is a respected author and a frequent speaker at major industry conferences. Howard received a PhD in Operations Research from Cornell University in 1968, and a BS in Physics from City College of the City University of New York in 1965.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, India
Investor stats
- Total investments: 67
- Round size: Seed $1M–$4.2M; Series A $1M–$4.7M; Series B $857k–$25M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- LexCheck — Transform your contract negotiation process with AI. Review, redline and approve contracts quickly and economically with the power of automation.
- UpdateAI — ChatGPT fine-tuned for customer success. Number One in automated recaps of post-sales calls. Customer follow-up emails written for you.
- HATCH — HATCH is the first of its kind Giving Intelligence Platform. An AI-powered portal for Fundraisers, Marketers and Volunteers to streamline and Maximize their impact. A new home for a new world of giving!
Ran Tuttnauer
Show more...Investment focus
- Industry: Health Care, Big Data, Medical Device
- Stage:Seed, Series A
- Geography: Israel, Canada, United States
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Innovopro — Bringing a unique chickpea protein platform to the global food & beverage market, for creating nutritious, tasty, and sustainable food products.
- Solidify — The Marketplayz platform helps you find the perfect creators to promote your products. It utilizes AI-powered technology to enable advertisers and creators to connect through a one-stop, self-service marketplace.
- Geneyx — Geneyx offers a superior NGS data analysis and interpretation platform, Harnessing genetic data to guide digital insights for rare and germline disorders Geneyx
Prof. Rafael Beyar
Show more...Investment focus
- Industry: Medical, Medical Device, Machine Learning
- Stage:Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MedHub-AI — MedHub-AI develops deep-learning video analysis algorithms that provide accurate diagnostic insights and practical guidance for physicians. Users can incorporate its algorithm into medical video systems to improve the decision-making process for cardiologists and other physicians. Its technology uses multiple technological and big-data processingmethods designed to handle a massive amount of clinical data, both visual and textual. It designs its algorithms to improve physicians' performance and shorten procedure times by providing a multilayered automated system that is implemented from diagnosis to practical procedural guidance and documentation. It currently offers solutions for the cardiology and gastroenterology markets.
Dr. Cabilly is a highly regarded scientist, an investor and an experienced Board Member of several companies. He is currently a Board Member of Medasense Biometrics Ltd. He previously worked for several companies including as the Co-Founder and a Chief Scientist of Ethrog Biotechnology which was sold to Invitrogen. Dr. Cabilly graduated fromthe Hebrew University (Ph.D., Immunology), and was a Post-Doctoral fellow at the City of Hope Research Institute heading a joint City of Hope/Genentech project where he developed a new technology for recombinant antibody production. This invention was patented in world patents “The old Cabilly” and “The New Cabilly patent”. Today there are already 20 drugs in the market based on this technology among which are Herceptin, Rituxan, Traceba, Raptiva, Xolair and more.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series B, Series C
- Geography: Israel, United States
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Treato — Treato automatically collects the massive amount of patient-written health experiences from blogs and forums and, with advanced Natural Language Processing (NLP), extracts relevant information, connects the dots and creates the big picture of what people say about their medications and conditions.Treato's big data analytics are availablein a consumer site and as an in-depth service for pharmaceutical marketers.Treato's Consumer site (
- DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Business entrepreneur and investor in startups. For the past 20 years developer of new initiatives and ideas. CEO, Chairman of companies, political strategist and advertising expert. Lead public opinion campaigns for people and issues from breast cancer, to national elections to the Israeli-Palestinian peace negotiations. Founding Partner atmybulb.vcOwner of the Gaon Holding Group; Executive Director in the group's companies, focusing on development and marketing products and services for the global Water Smart Grid. Member of the AquaAgro Fund Investment committee, a 50 Million dollar Israeli Venture Capital Fund, focused only on developing innovative water and agriculture technologies, as well as other innovative clean technologies.
Show more...Investment focus
- Industry: Advertising, Association, Social Media Marketing
- Stage:Seed, Series A, Convertible Note
- Geography: Israel, United States
Investor stats
- Total investments: 6
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Apester — Supercharge your marketing and funnel with interactive content experiences that generate more leads, engage and convert users, and boost retention
- Yoocan — Yooocan is an internet company developing the collaborative community-driven marketplace for people with disabilities. The company offers a global collaborative community and technology hub created for and by people with disabilities and their families to share experiences and knowledge. With Yoocan, a person with disabilities or the parent of achild with disabilities can share stories and tips easily explore and find activities, products, services, and innovations; and connect with others to make their lives easier and better.Yoocan is also an assistive technology hub, providing early-stage funding and support for start-ups in the disability-focused ecosystem, with more than 900 organizations, thousands of users from more than 100 countries, and hundreds of partners. They believe that shared experiences and knowledge from around the world can inspire people with disabilities and change their lives, so no one feels alone.Yoocan was founded in 2015 and is headquartered in Tel Aviv, Israel.
- IndieFlow — IndieFlow developed a workflow management platform for the music industry. The platform provides a centralized platform to manage music industry workflows and streamline the major building blocks of an artist’s career. It enables users to manage creative projects, distribute to streaming platforms, collect roylaties, register music with royaltycollection societies, promote music, book gigs, receive payments and more.
Mr. Zohar Gilon is a Managing Partner at Tamar Technology Ventures. He has personally invested in over 45 start-ups and has achieved 13 exits. Mr. Gilon has also served as the Transaction Manager for some of Israel's most highly recognized exits and has managed each deal from inception through completion, including pricing and distributions.He has extensive investment experience including activity as an angel investor and an Investment Advisor to the Gilon Group. Mr. Gilon is a private investor in numerous high-technology companies, including affiliates of Radcom Ltd. in Israel. From 1974 to 1993, Mr. Gilon served as the President of various companies representing major U.S. aerospace and electronics corporations. From November 1993 to August 1995, he served as the President of W.S.P. Capital Holdings Ltd. Previously he served, as the Managing Director of Shaked Technologies Ltd. He serves as a Director of HCL CleanTech Ltd., RIT, AVT Ltd., Oberon Media, Inc., Edge Medical, Exlibris, OrSense Ltd., and WisAir Ltd. He served as a Director of RAD Ventures. Mr. Gilon served as a Director of RiT Technologies Ltd. since 1995, Ceragon Networks Ltd. since June 1999, Radware Ltd. from October 2006 to July 2009 and Radcom Ltd. since June 1995. He served as Member of the Supervisory Board of Advanced Vision Technology (AVT) Limited. He served as an Outside Director of Silicom Ltd. since 1994.
Show more...Investment focus
- Industry: Software, Internet, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 32
- Round size: Seed $1.5M–$9.3M; Series A $1.6M–$11M; Series B $4.5M–$15M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- CADY — CADY's mission is to fully automate the inspection and verification of Printed Circuit Board (PCB) schematics, using AI technology.
- Loora — Unlock your full potential with Loora, your very own AI English tutor. Engage in real conversations with Loora anytime, anywhere, and on any topic!
- Everafter.ai — Build personalized hubs for every customer - from POC and onboarding plans to success plan and monthly communications. And the best part - embed it inside your product.
Dov Moran is the Managing Partner of Grove Ventures. He previously worked at modu as the Founder, Chairman, and CEO. Dov Moran attended Technion.
Show more...Investment focus
- Industry: Semiconductor, Hardware, Health Care
- Stage:Series A, Seed, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 22
- Round size: Seed $3M–$4.5M; Series A $1.2M–$23M; Series B $25M–$74M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Rapid — RapidAPI is an API Hub that enables over 3 million developers to find, manage, and connect to APIs. RapidAPI lets developers manage all API integrations from one place and gives real-time performance metrics. RapidAPI was founded in 2014 and is headquartered in San Francisco, California.
- Triple Jump Medical — Triple Jump Medical is a developer of an insulin pump intended to treat diabetic patients.
- Sensible Medical Innovations — Sensible Medical Innovation Ltd. is introducing a breakthrough sensing and monitoring technology providing actionable and accurate data for guiding the management and treatment of several chronic medical conditions representing today’s biggest burden on US and worldwide healthcare budgets.
Mr. Yehuda Zisapel (EE,MSc, MBA, DHC) is the founder and president of the RAD-Bynet Group, a leading pioneering association of Israeli companies active in the development, production and marketing of innovative solutions for the data communications industry, and Chairman of RAD. The RAD-Bynet Group grew out of Bynet Data Communications, whichMr. Zisapel founded in 1975 as a small private company that marketed data communications products. Bynet represented major international vendors and was the first to introduce cutting-edge technologies into the Israeli market. Today, the Bynet Group is comprised of eight companies active in both the Israeli and Eastern European markets in such fields as systems integration, cabling, testing, outsourcing, and software development. Following the arrival of Mr. Zisapel’s brother, Zohar, who joined him in 1981, a wide range of industrial activity was spawned from within the newly established RAD, the first of the RAD Group companies. In the years following its successful launch, twenty-four additional independent hi-tech companies were opened to develop, produce and market a wide variety of advanced data communications products.
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Series A, Seed
- Geography: Israel
Investor stats
- Total investments: 7
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Carteav — Our mission is to create and distribute autonomous low-speed vehicles (LSVs) that inspire mass-market adoption on a global scale.
- Rewire — Secure financial services designed to help migrants make cross-border money transfers. Rewire offers great rates, fast delivery, multilingual customer support
- Laminate Medical — Laminate Medical Technologies is developing a new, external support device for AV fistulas, to be implanted during the fistula creation surgical procedure. The VasQ Device alleviates wall tension and regulates fistula geometry where an undesired narrowing of the vein and/or frequent blockages of the blood vessels may occur during the firstyear. Use of Laminate Medical Technology’s novel device aims to drive a change in the hemodialysis vascular access treatment paradigm and bring about a significant reduction in the annual fistula failure rate, thereby reducing kidney-failure related complications, re-interventions, and the cost burden of vascular access complications.
Assaf Wand is the Founder and Executive Chairman of Hippo Insurance. He previously worked at Sabi (Sold to Urbio) as a Founder and CEO. Assaf Wand attended Reichman University (IDC Herzliya).
Show more...Investment focus
- Industry: Insurance, Health Care, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Brazil, France
Investor stats
- Total investments: 9
- Round size: Seed $3M–$6.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Fairmatic — Powered by data and AI, focused on rewarding fleet safety with savings. Finally, a smarter insurance option designed to put fleets in control.
- Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
- Modern Life — Modern Life is a tech-enabled life insurance brokerage. With a focus on empowering advisors, Modern Life offers advanced technology solutions to digitally streamline advisors’ practices and expert brokerage support. With Modern Life, advisors nationwide can compare quotes from top carriers in minutes, perform data-driven underwriting assessments,manage clients from an integrated dashboard, and receive comprehensive deal support.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Yaron Samid is an Israeli-American technology entrepreneur, investor, and startup community builder. Yaron is the founder of TechAviv, the 3K-member global Israeli startup founders club, and is the managing partner of TechAviv Founder Partners, a pre-seed venture fund, backed and powered by over 100 of the world’s most successful company builders.Previously, Yaron was the founder and CEO at BillGuard (Acq. by Prosper), founder & CPO at Pando (Acq. by Microsoft), and a founding board director at CloudLock (Acq. by Cisco) and Pond5.Yaron lives in Tel Aviv with his family and is a regular guest lecturer at Stanford and Columbia Business School. He attended Technion - Israel Institute of Technology and the University of Maryland.
Show more...Investment focus
- Industry: Software, Apps, Cyber Security
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Israel, Brazil
Investor stats
- Total investments: 16
- Round size: Seed $4M–$13M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- bxblue — bxblue is a marketplace for personal loans in Brazil explicitly targeting pensioners and Government workers because they can they take loans secured by their guaranteed income. Because of that banks can deduct the payment directly from the paycheck, leading to an apr 10x lower than credit cards. Payroll secured loans are the most affordablepersonal loan in Brazil, and they represent 60% of the personal loans in the country. It is a 40bn dollar/year marke, completely offline. We are taking this entire market online.
- Emedgene — Applying machine learning to genomics. Accelerate NGS data analysis and automate variant classification with evidence curated from the literature. From sample to report.
- Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
Ron C
Show more...Investment focus
- Industry: Health Care, Therapeutics, Medical Device
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.
Shimon Eckhouse
Show more...Investment focus
- Industry: Medical, Biotechnology, Fitness
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
- Epitomee Medical — Epitomee develops paradigm-shifting ingestibledevices that deploy targeted therapies along the GI tract
Mazal CB
Show more...Investment focus
- Industry: Health Care, Therapeutics, Medical Device
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.
Lewis Pell was appointed to our Board of Directors and was unanimously elected to serve as Non-Executive Chairman of the Board on December 12, 2011. Pell was a member of Radiancy’s Board since 1998. Pell has founded over a dozen successful medical technology companies during the past three decades. In 1979, he founded Pentax PrecisionInstruments, which was sold to Asahi Optical Co. in 1990. In 1983, he founded American Endoscopy Inc., which was sold to C.R. Bard, Inc. (BCR-NYSE) in 1986. In 1984, he founded Versaflex Inc., which was sold to Medtronic in 1988. In 1989, he founded Heart Technology Corp., which went public in the U.S. in 1992 and was sold to Boston Scientific Corp. (BSX-NYSE) in 1995. In 1991, he founded InStent Inc., which became a public company in 1995 and was sold to Medtronic in 1996. In 1994, he founded Influence Inc., which was sold to American Medical Systems Inc. in 1999. Working with Shlomo Ben-Haim, Pell founded Biosense Inc. in 1994, which was sold to Johnson & Johnson in 1997. He is currently chairman and an investor for a number of private medical device companies. In 1992, he founded and remains the chairman of Vision-Sciences, Inc. (VSCI-NASDAQ). Pell has a B.S. in political science from Brooklyn College and over 20 years of experience in the medical technology industry. Pell was selected to serve on the Company’s board because of his over thirty-years’ experience in leadership roles in the medical device industry.
Show more...Investment focus
- Industry: Health Care, Therapeutics, Medical Device
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
Avishai Abrahami is our Co-Founder, has served as our Chief Executive Officer since September 2010 and was our Co-Chief Executive Officer and a director since October 2006. From 2004 to 2006, Avishai was the Vice President of Strategic Alliances at Arel Communications & Software Ltd., a private Israeli company specializing in communicationtechnology. In 1998 he co-founded Sphera Corporation, a private company which develops software for managing data centers, and he served as its Chief Technology Officer from 1998 until 2000 and its Vice President of Product Marketing from 2000 until 2003. In 1993, he co-founded AIT Ltd., a private Israeli software company, and served as its Chief Technology Officer until the company's sale in 1997. Avishai served in the Israeli Defense Forces' elite computer intelligence unit from 1990 until 1992.
Show more...Investment focus
- Industry: Software, Internet, Social Media
- Stage:Seed, Series A, Pre-Seed
- Geography: Israel, United States, Italy
Investor stats
- Total investments: 10
- Round size: Seed $250k–$9.5M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Affogata — Affogata optimizes the digital customer journey by analyzing customer interactions and identifying customer needs in real-time.
- Connecteam — Communicate, operate and train your non-desk employees with Connecteam's all-in-one employee app. Easy to use, customizable and affordable like no other!
- The Gist — The Gist for Slack is our first app to manage your work information overload. Get the gist of it with our personalized AI enginge.
Ronald Cohen is Chairman of the Global Social Impact Investment Steering Group and The Portland Trust. He is a co-founder director of Social Finance UK (2007-11), Social Finance USA, and Social Finance Israel, and of Big Society Capital. He was co-founder Chair of Bridges Ventures (2002-2012).He chaired the Social Impact Investment Taskforceestablished under the UK’s presidency of the G8 (2013-2015), the Social Investment Task Force (2000-2010) and the Commission on Unclaimed Assets (2005-2007). In 2012 he received the Rockefeller Innovation Award for innovation in social finance.He co-founded and was Executive Chairman of Apax Partners Worldwide LLP (1972-2005). He was a founder director and Chairman of the British Venture Capital Association and a founder director of the European Venture Capital Association.He is a graduate of Oxford University, where he was President of the Oxford Union. He is an Honorary Fellow of Exeter College, Oxford. He has an MBA from Harvard Business School to which he was awarded a Henry Fellowship.He is a member of the Board of Dean’s Advisors at Harvard Business School and Vice-Chairman of Ben Gurion University. He is a former director of the Harvard Management Company and the University of Oxford Investment Committee. He is a former member of the Harvard University Board of Overseers (2007-2013), former Trustee of the British Museum (2005-2012) and a former trustee of the International Institute for Strategic Studies (2005-2011).In 2007, Sir Ronald published: “The Second Bounce of the Ball – Turning Risk into Opportunity”.
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Series A, Seed
- Geography: Israel, United States, Poland
Investor stats
- Total investments: 18
- Round size: Series A $1.7M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Selina — Selina is one of the world’s fastest growing hospitality brands, combining beautifully-designed accommodation with coworking spaces, wellness, recreational offerings and local experiences for today’s nomadic traveler to live, work and explore anywhere in the world.With a design-centric, technology-first and socially-minded approach to travel,Selina currently operates 24 urban, beach, jungle and mountain-side locations across eight countries and is developing a global infrastructure for nomads who want to make the world their classroom, office, and playground.
- Circles - Online Group Support — Participate in online video meetings guided by an expert facilitator and gain tools for reflection that will help you feel less alone.
- Masterschool — Masterschool partners with tech industry leaders to help you build your dream career. Learn online, get unlimited career support, and pay no tuition until you find a job.
Lyndon Babtiste
Show more...Investment focus
- Industry: mHealth, Blockchain, Health Care
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Proof Work — Proof puts patients medical data on a decentralized secure platform and ledger for personal ownership, interoperability and a lifetime history of care. For free. In two minutes your health data is secured on the blockchain. It's as easy as that.Our solution makes data more private and liquid costs less to administer and provides a real-timelifesaving flow of medical data.This same medical data becomes an intrinsic valuable digital passport arising from the users prerogative for permission-based access control.Rights can be granted or traded to either another patient, payer or provider such as doctor, insurer, hospital, pharmacy, nurse, caregiver, family or friend.
Beni Nofech is a food-tech investor.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Nutrition
- Stage:Pre-Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Remilk — Remilk is a food-tech company that uses microbes to produce the key ingredients in milk. The company is developing technology for creating a milk substitute that is similar to cow milk in flavor, nutritional composition, composition, and functionality. It was founded in 2019 and is based in Tel Aviv, Israel.
- Oshi — Alternative Protein - Stealth Mode
- Mush Foods — Mush Foods is an Israeli-based food tech company, growing edible mushroom mycelium to create innovative and sustainable animal-free protein as an ingredient for the food and beverage industry. We harness the fantastic power and innate intelligence of mushrooms to face future global challenges and provide sustainable groundbreaking food solutions tothe food of the future.
Lily Sarafan is the Executive Chair of TheKey. She is also an Operating Partner at Cota Capital.An active Stanford alum, Lily serves on the Stanford Alumni Association Board of Directors, the Freeman Spogli Institute Council, and the Stanford Undergraduate Education Cabinet. She is also Founding Partner of Project BIG: The Stanford Brain ImmuneGut Initiative. Lily's board service extends to other high-impact nonprofits including the Women's Alzheimer's Movement and the BerkeleyHaas Center for Innovation Economies, where she is board chair. An appointee to the California Governor’s Alzheimer's Task Force, Lily serves in various leadership roles to advance economic development, civic engagement, and precision health.Lily holds an M.S. in Management Science and Engineering and B.S. in Science, Technology, and Society from Stanford University, where she was Eben Tisdale Fellow and Class President. She has been named Ernst & Young Entrepreneur of the Year, Women Health Care Executives Woman of the Year, and a Silicon Valley 40 Under 40. Lily is a Member of Young Presidents' Organization, a Term Member of the Council on Foreign Relations, a Henry Crown Fellow of the Aspen Institute, and a World Economic Forum Young Global Leader.
Show more...Investment focus
- Industry: Health Care, Wellness, Enterprise Software
- Stage:Seed, Series A
- Geography: United States, Israel
Investor stats
- Total investments: 6
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Seniorly — Seniorly helps families and older adults find the right senior living for their needs and budget. Combining the power of machine learning with the high-touch support of a national network of local advisors, Seniorly is modernizing senior living discovery. Through its online platform, Seniorly provides access to thousands of senior livingcommunities, expert insights, and personalized recommendations based search preferences. Seniorly also has a growing marketplace of trusted companies, offering other services and products that are helpful to families at this stage of life. Founded in 2014, Seniorly currently supports over 5 million visitors every year on their senior living journey. Visit http://www.seniorly.com for more information.
- January AI — Founded in 2017 by Silicon Valley veteran Noosheen Hashemi, January is a Menlo Park based pre-launch precision health start-up. Born in response to a healthcare system designed to address decline and disease, January is creating a completely new upstream consumer health category focused on an integrated approach to taking charge of one’s ownbiology through the multi-omic science of health. Together with the personal health data and a strong underpinning of machine learning, January provides individuals multidimensional information about their health in a simple and actionable way through their suite of software and consumer products.
- NeuraLight — Transforming clinical development, diagnostics, and precision medicine in neurology with AI. We are building an AI-driven platform to accelerate and improve drug development and patient monitoring, as well as introduce precision care for patients with neurological disorders using oculometric data captured with a standard webcam or smartphone.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!David Agus is an American physician and a New York Times bestselling author. He is a Professor of Medicine and Engineering at the University of Southern California. He is co-founder of Navigenics, a personalized medicine company and Applied Proteomics, as well as a CBS News contributor.
Show more...Investment focus
- Industry: Health Care, Health Diagnostics, Artificial Intelligence
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Imagene AI — Image-based H&E Biomarkers Profiling in Real-time
Rick Klausner is a Chief Executive Officer at Lyell Immunopharma.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Life Science
- Stage:Series A, Series B, Series E
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 8
- Round size: Series A $30M–$42M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
- Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
- LifeMine Therapeutics — What if the solutions to the greatest unsolved medical problems of our time had already been evolved in nature, hiding in plain sight as molecules waiting to be mined? What if revolutionary discoveries in emerging scientific fields from gigascale DNA sequencing to artificial intelligence and synthetic biology had advanced, such that we finally had a way to mine the biosphere and bring transformative new medicines to patients in need? Our answers to these questions drive the passion and mission at LifeMine Therapeutics.
Moshe Shoham
Show more...Investment focus
- Industry: Medical, Health Care, Artificial Intelligence
- Stage:Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Predicta Med — Predicta Med is a decision support platform for early detection and intervention selection of autoimmune diseases. Our platform gives healthcare providers an AI-powered method for shortening the diagnostic process of identifying autoimmune diseases and by that could enhance provider’s efficiency, improve treatment effectiveness and patient'scare. A process which typically takes more than four years and at least four different doctors can be shortened significantly using our platform.
Alan Patricof is the founder and Chairman Emeritus and was a managing director of Greycroft. He is a Co-founder and Chairperson at Primetime Partners and was a Founder at Apax Partners. Alan attended Columbia Business School and The Ohio State University.
Show more...Investment focus
- Industry: Health Care, Financial Services, Finance
- Stage:Series A, Seed
- Geography: United States, Kenya, Spain
Investor stats
- Total investments: 31
- Round size: Seed $1.5M–$4M; Series A $3.2M–$15M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Leena AI — Leena AI enhances employee experience via HR helpdesk automation and employee engagement software.
- Racket.com — Let's make a racket.
- Alpha Tau Medical — Alpha Tau Medical provides highly potent and conformal Alpha Radiotherapy (Alpha DaRT) for solid cancer tumors.
Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering.
Show more...Investment focus
- Industry: Software, E-Commerce, Food and Beverage
- Stage:Series A, Seed, Series B
- Geography: The Netherlands, France, Israel
Investor stats
- Total investments: 26
- Round size: Seed $1.8M–$7M; Series A $6.9M–$20M; Series B $7M–$78M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Fairbrics — Fairbrics is developing the first synthetic fiber with a net positive impact on climate change and capable of meeting the demand of the market.
- FononTech — FononTech specializes in impulse printing.It is used to print small electronic circuits for electronic devices.
- Mermade Seafoods — Mermade is a pioneering cellular aquaculture company, bringing a novel approach and mindset for the production of cell based seafood.
Nancy Spielberg - Advisory Board Member @ The Elegant Monkeys
Show more...Investment focus
- Industry: Wearables, Health Care, Machine Learning
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- The Elegant Monkeys — We have gathered top data science talents and world-class researchers to make emotions measurable.Digitizing human emotions opens endless applications in health, performance and lifestyle. It is a subscription-based API/SDK that utilizes AI algorithms to extract emotional state from physiological sensors data. Using physiological dataenables our customers to get emotions data without compromising usability and privacy.
Zohar Zisapel
Show more...Investment focus
- Industry: Cyber Security, Information Technology, Security
- Stage:Series A, Seed, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 26
- Round size: Seed $2.6M–$8M; Series A $7M–$17M; Series B $15M–$18M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Cylus — Cylus, the global leader in rail cybersecurity, helps rail, freight and metro companies avoid service disruption and safety incidents by detecting cyber-attacks in their signaling and control networks, wayside and onboard, before harm happens.
- Nucleix — OUR TESTS AIM TO DETECT CANCER EARLIER - WHEN TREATMENT CAN BE MOST EFFECTIVE FOR PATIENTS OUR PRODUCTS
- Hailo — Hailo have developed the best performing AI processors for edge devices. Our AI accelerator chips are used for Smart City & Homes, machine learning, automotive AI, retail AI and smart factory Industry 4.0 solutions.
Daniel Koss is an individual investor.
Show more...Investment focus
- Industry: Medical Device, Clinical Trials, Health Diagnostics
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
Haim Chizic is an individual investor.
Show more...Investment focus
- Industry: Medical Device, Clinical Trials, Health Diagnostics
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
Tzachi Arabov is a owner of ACRO.
Show more...Investment focus
- Industry: Medical Device, Clinical Trials, Health Diagnostics
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Josh Riff is the co-founder of Included Health.
Show more...Investment focus
- Industry: Software, Wellness, Analytics
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Laguna Health — Laguna is a tech company solving a huge, costly problem in US healthcare. We provide easier post-hospitalization recovery soultions.
Anne Wojcicki is the Co-Founder and CEO of 23andMe. She previously worked at Passport Capital as a Healthcare Analyst. Anne Wojcicki attended Yale University.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 51
- Round size: Seed $765k–$10M; Series A $7M–$20M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- Calypso AI — CalypsoAI combines industry-leading AI testing and human-in-the-loop decision making to give you the confidence you need to push AI projects into production.
- Eureka Health — Helping people with chronic conditions mitigate their symptoms.
- Helium Health — Helium Health empowers healthcare providers in Africa with digital tools, financing solutions, and data partnerships. Learn more about our innovative solutions.
Ole T. Jensen
Show more...Investment focus
- Industry: Biotechnology, Medical Device
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Nobio — NobioTM developed game-changing technology with the goal to prevent medical device contamination indefinitely, as the first and only fully-integrated anti-biofilm solution. The technology core consists of extremely potent particles which are covered with a high concentration of highly-active anti-microbial structures that kill bacteria uponcontact. The NobioTM particles can be permanently embedded in many products and materials to inhibit formation of biofilm, indefinitely.
Romain spearheaded the digital strategy of Alain Afflelou Group before becoming an investor in numerous start-ups. He uses his fine-tuned analysis skills to support and invest in innovative start-ups. In addition to being a major shareholder and Co founder of Cosmo Connected a French start-up specialized in connected objects related to security andmobility.Romain is Director and Board member of Multiwave Technologies /develops breakthrough metamaterial technologies to improve people's lives.Serial investor in +50Tech companies6over6 (Acquired by 1-800 contacts) Cityscoot Clay Inc VR Cowboy Bike Epicery Everoad (Ex Convargo) Fithouse Fré Skincare Fokoya Guillotine Vodka Klassroom Laminate Technologies MeetFabric Molotov TV Multiwave Technologies Nestor Octopus Officeriders Onoff telecom Pledg Quiqup Universal Standard Shapr Spendesk Zipdrug...(Acquire by Anthem Pharmacy)
Show more...Investment focus
- Industry: Health Care, FinTech, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: France, United States, Israel
Investor stats
- Total investments: 30
- Round size: Seed $1M–$7.5M; Series A $5.9M–$43M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cashbee — Cashbee is a mobile application to helps save money with budget analysis tools based on artificial intelligence. They wish to help the French to save better and more, and to provide the technological means to do this in the simplest possible way, without having to change banks. The Cashbee App allows you to put money aside with a simple swipe onyour smartphone. They alert you every time when they think you can put some more cash aside.
- Kate — Kate redefines everyday mobility by offering electric vehicles made in France.
- Kubo Labs — Kubo Labs provides a suite of products to simplify your experience with Kubernetes.
Dr Mansi is a former Neurosurgeon and the CEO of Viz.ai an Applied AI Healthcare company.They recently received FDA clearance for the first ever AI aided triage and notification platform, opening the door to AI in acute emergency healthcare. Chris is a clinician innovator, entrepreneur and optimist focused on increasing healthcare access, buildingand supporting great teams and improving provider experience. Viz.ai builds clinician facing products that enable and empower doctors, allowing them to provide the best care to patients, everytime, everywhere.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Series A
- Geography: United States, Israel
Investor stats
- Total investments: 3
- Round size: Series A $13M–$25M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Canopy — Canopy's intelligent care platform enables practices to improve cancer patients' experience and outcomes in an ever changing oncology environment.
- HumanFirst — HumanFirst enables better integration and analysis of digital health technologies in clinical trials.
- NeuraLight — Transforming clinical development, diagnostics, and precision medicine in neurology with AI. We are building an AI-driven platform to accelerate and improve drug development and patient monitoring, as well as introduce precision care for patients with neurological disorders using oculometric data captured with a standard webcam or smartphone.
Brock Weatherup is the CEO/Founder of Metamorphosis Partners driving enterprise value through innovation in the $80B pet industry focused on the consumer. Brock was most recently the EVP of Strategic Innovation & Digital Experience at Petco. Previously he was CEO & CoFounder of PetCoach (acquired by Petco) - revolutionizing the PetHealth Care experience. Brock is a CEO, entrepreneur, angel investor, builder of enterprise value and passionate advocate about the consumer and their interactions with digital media & Ecommerce. Brock is also managing partner of Atai Ventures angel investments, co-founder of ICONYC (www.iconyclabs.com) an early stage NYC based Israeli accelerator, investor/advisor/board member for 7+ startups - VeryApt, SideCar, Social Ladder, Ethology and an industry advisor for VC firms EQT Partners, MissionOG & SafeGuard. Previously Brock was SVP/Chief Digital Officer of Petsmart after selling Pet360 where he was CEO the prior 5 years. Brock was also CEO of Fathead and held several leadership positions with InterActiveCorp (Ticketmaster, Match.com, CitySearch, ReserveAmerica). A graduate of University of Colorado Boulder, sits as a board member of the Nature Conservancy – Adirondacks, father of two amazing girls and pet owner to my 4yr old retriever named...Boulder.
Show more...Investment focus
- Industry: EdTech, Medical, mHealth
- Stage:Seed
- Geography: Israel, United States
Investor stats
- Total investments: 2
- Round size: Seed $550k–$880k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Myndlift — Myndlift offers a therapist-guided home neurofeedback solution for mental health, using mobile and wearable technology. Home users enjoy accessible and affordable training while neuro-therapists can grow their practices with remote supervision.
- Amplio — Amplio is a powerful special education solution that combines a learning management system with built-in programs & evidence-based curricula.
Ariel Yaar - VP Research and Development @ Readz
Show more...Investment focus
- Industry: Software, Health Care, CRM
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 5
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- GearEye — Gear Eye: the ultimate tracking solution for your gear. Manage and locate your equipment tagged with battery-free RFID tags and stickers. Never lose your items.
- DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.
- BioChange Ltd. — BioChange has developed a breakthrough technology for tissue regeneration, A unique injectable scaffold that stimulates tissue repair. For info Click here
Robert Nelsen is a co-founder and a Managing Director of ARCH Venture Partners. He joined ARCH at its founding and played a significant role in the early sourcing, financing and development of more than 100 companies, including nineteen which have reached valuations exceeding $1 billion. His seed and early-stage investments include Illumina (ILMN);Alnylam Pharmaceuticals (ALNY); Juno Therapeutics (JUNO); Unity Biotechnology (UBX); Sienna Biopharmaceuticals (SNNA); Vir Biotechnology, Agios Pharmaceuticals (AGIO); Sage Therapeutics (SAGE); GRAIL, Ikaria; Kythera Biopharmaceuticals (KYTH), Receptos (RCPT); Aviron (AVIR); Denali Therapeutics (DNLI); Rubius Therapeutics, KSQ Therapeutics, Beam Therapeutics, NetBot; Bluebird Bio (BLUE); R2 Technology; XenoPort (XNPT); Caliper Life Sciences (CALP); Trubion Pharmaceuticals (TRBN); Adolor (ADLR); deCODE Genetics; Array BioPharma (ARRY); Editas (EDIT), IDUN Pharmaceuticals; Classmates.com; Hua Medicine; Fate Therapeutics (FATE); WuxiNextCODE; and Everyday Learning Corporation.Mr. Nelsen is a director of Vir Bio, GRAIL, Sienna Biopharmaceuticals, Beam Therapeutics, Unity Biotechnology, Denali Therapeutics, Arivale, Syros Pharmaceuticals, and serves as Chairman of Hua Medicine, among others. He previously served as a Trustee of the Fred Hutchinson Cancer Research Institute, the Institute for Systems Biology, and was a director of the National Venture Capital Association. Mr. Nelsen holds an M.B.A. from the University of Chicago and a B.S. from the University of Puget Sound with majors in Economics and Biology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 68
- Round size: Series A $15M–$100M; Series B $20M–$60M; Series C $30M–$167M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Gameto — Gameto is a new breed of biotechnology company in female reproductive longevity
- Katalyst — With one strength training session, you'll get a full-body workout in 20 minutes, with no external loads or joint impact. The Katalyst Training System uses low frequency impulses to stimulate and contract up to 90% of the muscle fibers in your body, for an intense workout equivalent to spending 2+ hours in the gym.
- Colossal Biosciences — Colossal is a ground-breaking bioscience and gene engineering firm that develops cutting-edge genomics technology.
Gigi Levy Weiss is the General Partner at NFX. He attended Tel Aviv University and the Finance Department - Kellogg School of Management.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 68
- Round size: Seed $400k–$8M; Series A $3.5M–$30M; Series B $6.5M–$45M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Shamaym — Continuous Improvement Platform helps teams get better every day and drive better outcomes in product development, sales, support, and more.
- Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
- Diagnostic Robotics — Diagnostic Robotic develops a signal-agnostic artificial intelligence system for healthcare insurers, providers, and patients. It allows to build powerful predictive analytics models that will solve a world-wide challenge, strained health budgets, and workforces. Diagnostic Robotic was founded on 2017 and is headquartered in Tel Aviv, Israel.
Noam Soloman is the CEO and co-founder at Immunai, the first and only company to map the entire immune system for better detection, diagnosis, and treatment of disease. Leveraging single-cell technologies and machine learning algorithms, Immunai has mapped out thousands of immune cells and their functions, building the largest proprietary data setin the world for clinical immunological data. Prior to co-founding Immunai, Noam had a dual career in both the industry and academia. Noam is a double Ph.D., and served as a post-doctoral researcher in the Mathematics department at MIT, and in the center of mathematical sciences and applications at Harvard University. In his research, he developed and applied tools from algebra and Algebraic Geometry in the study of classical problems in combinatorics. Noam also worked as an algorithms developer in the Israeli defense forces and subsequently as a data scientist, consultant and head of data science in several hi-tech companies in Israel.
Show more...Investment focus
- Industry: Software, Wellness, Health Care
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- NeuraLight — Transforming clinical development, diagnostics, and precision medicine in neurology with AI. We are building an AI-driven platform to accelerate and improve drug development and patient monitoring, as well as introduce precision care for patients with neurological disorders using oculometric data captured with a standard webcam or smartphone.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Shahar is a Managing Partner at TLV Partners I, II, III. Shahar is a board member in Aidoc, Buildots, Canopy Immuno-Therapeutics, Deepcure, EverAfterAI, Granulate, Guesty, Hunterz, Immunai, Odo, ScyllaDB, Shookit, Silverfort.Before joining TLV Partners Shahar was a General Partner at Magma Venture Partners III and IV and was a board member inAidoc, Applitools, CloudEndure (acquired by Amazon), Coretigo, Guesty, Indegy (acquired by Tenable), ScyllaDB, Syte, Teridion, Tonkean
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Seed $3M–$4M; Series A $3M–$40M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Aidoc — Powered by an exclusive aiOS, Aidoc is trusted by 1,000+ hospitals to support physician decision-making at all points of care. See how our connected system of intelligence works.
- Buildots — Buildots specializes in transforming construction sites into a data-driven digital environment. Its platform enables maximum control of construction processes at minimal effort. The solution turns every site walk into valuable process data that can immediately be used for gaining full control of a certain project.
- DeepCure — Pioneering a new frontier in drug development. DeepCure is building an AI engine for small-molecule drug discovery.
Larry Ellison is executive chairman of Oracle Corporation and chief technology officer. He founded the company in 1977 and served as CEO until September 2014. He also races sailboats, flies planes, and plays tennis and guitar.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series C, Series G
- Geography: United States, Spain, Israel
Investor stats
- Total investments: 14
- Round size: Series C $20M–$50M; Series G $11M–$20M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Imagene AI — Image-based H&E Biomarkers Profiling in Real-time
- Kosmos Tennis — Kosmos Tennis is pleased to announce the launch of www.daviscupfinals.com, which will be operational as of 22nd January, to keep the public informed about all aspects of the new Davis Cup Finals. The new website provides easy and intuitive access to all aspects of the new competition format, especially the finals, which will bring 18 national teamstogether in the same city over the course of a week. The new website will also report on the most significant events of the qualifiers set to take place in February.
- Quark Pharmaceuticals — Founded in 1994, Quark devoted its early years to developing its innovative technology platform for identification of novel functional target genes and proteins, the “BiFAR†technology. The basic concept, patented by Quark, of high throughput gene inactivation combined with microarray detection of the functional genes responsible for theoccurrence of phenotypes of interest, was at that time revolutionary. With the advent of siRNA technology, Quark's approach is rapidly becoming the technology of choice for functional studies industry-wide. We have applied our BiFAR platform in gene discovery programs in serious diseases with significant unmet medical needs, often in collaboration with large pharmaceutical partners. Today we are harvesting the fruits of the innovative targets and concepts we identified.
Rafi Gidron is the Chairman and Co-Founder of Xperiti. He attended Columbia University.
Show more...Investment focus
- Industry: Artificial Intelligence, Cyber Security, Analytics
- Stage:Seed, Angel, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 18
- Round size: Seed $3M–$8M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Blyp — Blyp is an AI-driven data analytics platform for e-commerce companies.
- CADY — CADY's mission is to fully automate the inspection and verification of Printed Circuit Board (PCB) schematics, using AI technology.
- GlossAI — GlossAi turns your impossibly long, but precious content, into an endless source of compelling share-worthy videos for the various uses of your target audience.
For the last 10 years, I have been active within the Israeli and US startup ecosystems where I completed 20+ seed investments in companies such as Geoforce (acquired by LLR), Bonobo (acquired by Salesforce), Optitex (acquired by Efi), Keeprz (acquired by Como), Drippler (acquired by Soluto), Snyk (Unicorn) and few others. I am passionate for seedinvestments, creative ideas, risk taking and supporting entrepreneurs.Prior to that, I founded 2 companies, Blue Sky (Energy) and Sinusafe (Medical) after working as a software engineer for 7 years.I grew up in Israel, and lived in the US for 5 years while completing my MBA from Duke. I love all kinds of extreme sports, and particularly kite surfing and snowboarding.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 22
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Laxis — Learn how UX designers, product managers, market research, consultants, and attorneys use conversation Intelligence to supercharge their business and increase revenue. Learn more.
- Deci AI — Deci empowers deep learning developers to accelerate inference on edge or cloud, reach production faster, and maximize hardware potential.
- Velocity — Accelerate the way you build and deliver products. Spin up fully isolated, production-like environments in seconds. Work with your existing dev toolbox.
HealthTech angel
Show more...Investment focus
- Industry: Software, Health Care, mHealth
- Stage:Seed, Debt Financing
- Geography: United States, Israel
Investor stats
- Total investments: 4
- Round size: Seed $1.6M–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Authorea — Authorea is a provider of a collaborative platform that is designed to read, write, discuss, and publish research. Its platform serves as a powerful document editor for researchers and provides collaborative editing, automatic citation formatting, tracking changes and it has the ability to make any document public or fully private that enablesresearchers to write documents together and attach references, figures, data, and source code. It improves how researchers work and make breakthrough discoveries by tackling one of the most important parts of the research cycle which is communication.
- ActiveProtective —
- Photosonix Medical — Photosonix Medical develops CLENS™ (Coincident Light Energy and Non-focused ultraSound), an energy-based therapy which synergistically combines light and ultrasound to treat chronic bacterial infections known as biofilms. The company targets dermal diseases, specifically moderate to severe acne. Its target prescribers include dermatologists andprimary care physicians.Photosonix Medical is based in Ambler, Pennsylvania.
Bradley M. Bloom is the Managing Director at Berkshire Partners.
Show more...Investment focus
- Industry: Food and Beverage, Sports, Fitness
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Perch — Perch brings velocity based training into the 21st century. No strings. No wearables. Learn more about how Perch enables VBT and weight room technology!
- Amai Proteins — With our Pro3 Platform technology, we develop tasty, healthy, sustainable, and cost-effective designer platforms for food and beverage applications.
- Diagnostic Robotics — Diagnostic Robotic develops a signal-agnostic artificial intelligence system for healthcare insurers, providers, and patients. It allows to build powerful predictive analytics models that will solve a world-wide challenge, strained health budgets, and workforces. Diagnostic Robotic was founded on 2017 and is headquartered in Tel Aviv, Israel.
David E. Weekly is the Founder and CEO of Medcorder and he was the Founding Director of Hacker Dojo. He has a bachelor's degree in Computer Science from Stanford University.
Show more...Investment focus
- Industry: Robotics, Drones, Aerospace
- Stage:Seed, Angel, Pre-Seed
- Geography: United States, Israel
Investor stats
- Total investments: 12
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mast Reforestation — No-cost reforestation for post-wildfire burned acreage for landowners and foresters, funded by carbon removal credits.
- Sugarlogix — A precise reflection of human milk to provide the best nutrition for babies
- Mast Reforestation — No-cost reforestation for post-wildfire burned acreage for landowners and foresters, funded by carbon removal credits.
Eyal Gura is the Board Member of Imagene AI. He previously worked at Zebra Medical Vision Ltd as a Co-Founder, President and Chairman of the Board. Eyal Gura attended Reichman University (IDC Herzliya).
Show more...Investment focus
- Industry: Software, Mobile, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, Belgium
Investor stats
- Total investments: 24
- Round size: Seed $1M–$2M; Series A $7.1M–$19M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Theator — Discover the world's first surgical intelligence platform from theator. Continually perfect your craft with AI & computer vision technology.
- Taranis — Taranis provides farmers with innovative and accurate precision agriculture solutions, powered by AI and machine learning, to optimize crop yields and streamline farm operations. Learn more about our cutting-edge technology. Request a demo today.
- Imagene AI — Image-based H&E Biomarkers Profiling in Real-time
Vivek Garipalli was the Co-Founder, CEO, and Board Member of Clover Health. He attended Emory University.
Show more...Investment focus
- Industry: Health Care, Medical, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: United States, India, Brazil
Investor stats
- Total investments: 23
- Round size: Seed $1.4M–$16M; Series A $3.6M–$12M; Series B $35M–$100M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Thyme Care — Thyme Care is a dedicated team of nurses and care experts offering value-based cancer care to help you through all phases of the cancer experience.
- Uplift — Rebuilding mental healthcare to work for everyone
- NeuraLight — Transforming clinical development, diagnostics, and precision medicine in neurology with AI. We are building an AI-driven platform to accelerate and improve drug development and patient monitoring, as well as introduce precision care for patients with neurological disorders using oculometric data captured with a standard webcam or smartphone.
Amir Gross is the CEO of Cardiovalve.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BrainQ — BrainQ is developing breakthrough precision neurology therapies using Brain Computer Interface technology....
Health Care Angel investor funding in Israel at a glance
Stats across 78 deals from 82 investors.
Access all 82 angel investors in Israel Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care Angel Investors in Israel investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 82 angel investors investing in Israel Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!